O'Shaughnessy Asset Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

O'Shaughnessy Asset Management’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-154	Closed	-$1K	–	2821
2021 Q3	$1K	Buy	154 +13	+9%	+$68	﹤0.01%	2693
2021 Q2	$1K	Hold	141	–	–	﹤0.01%	2554
2021 Q1	$1K	Buy	141 +53	+60%	+$379	﹤0.01%	2351
2020 Q4	$1K	Buy	+88	New	+$434	﹤0.01%	2050

Other funds holding MACK

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BCM

Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WIM

Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

O'Shaughnessy Asset Management's MACK Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2021, closing a stake of 154 shares — an estimated $1K sold.

O'Shaughnessy Asset Management first reported a position in MACK in Q4 2020 and held it in 4 quarters. The position peaked at $1K in Q3 2021. 38 funds tracked by Wall St. Rank hold MACK as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 154 Merrimack Pharmaceuticals, Inc. shares in Q4 2021, an estimated $1K.
O'Shaughnessy Asset Management first reported a position in Merrimack Pharmaceuticals, Inc. in Q4 2020 and held it in 4 quarters.
O'Shaughnessy Asset Management's Merrimack Pharmaceuticals, Inc. position peaked at $1K in Q3 2021.
38 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.